Somatuline for subcutaneous injection 120 mg (YJ code: 2499413G3028, standard: 120mg x 1 bottle), manufactured by Teijin Pharma, contains lanreotide acetate. This somatostatin analog is used to treat acromegaly and advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), with the 120 mg dosage typically administered every four weeks.
Somatuline for subcutaneous injection 120 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →